Risk factors and management of laryngeal edema after chimeric antigen receptor (CAR) T-cell therapy (IMAGE)

Juntendo University Research Promotion Center

Risk factors and management of laryngeal edema after chimeric antigen receptor (CAR) T-cell therapy

Caption

Laryngeal edema is a severe adverse effect of CAR T-cell therapy in patients with refractory or relapsed B-cell lymphomas

Credit

Dr. Erina Hosoya from Juntendo University, Japan

Usage Restrictions

You are free to share and adapt the infographic material but attribution is required, with a link to the news source.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.